We are live on ! Find out more
ZVSA

ZyVersa Therapeutics

Delisted

ZVSA was delisted on the 16th of July, 2025.

7 hedge funds and large institutions have $43.9K invested in ZyVersa Therapeutics in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

0.51% less ownership

Funds ownership: 3.23%2.72% (-0.51%)

13% less funds holding

Funds holding: 87 (-1)

49% less capital invested

Capital invested by funds: $86.2K → $43.9K (-$42.3K)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
1
UBS Group
Switzerland
$17.8K +$27.2K +24,140 +577%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$13.6K +$24.5K +21,706 New
VF
3
Virtu Financial
New York
$11K -$8.72K -7,732 -31%
TRCT
4
Tower Research Capital (TRC)
New York
$1.35K -$1.5K -1,328 -38%
Bank of America
5
Bank of America
North Carolina
$70 +$2 +2 +2%
SS
6
SBI Securities
Japan
$31
Morgan Stanley
7
Morgan Stanley
New York
$1
Citigroup
8
Citigroup
New York
-$37.1K -35,035 Closed
Renaissance Technologies
9
Renaissance Technologies
New York
-$13.7K -12,961 Closed